chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: The vial was expired on 24-Mar-2022 and removed from freezer just prior to administration time on 04-Apr-2022 at 10:26; administered with an expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine) and PRODUCT STORAGE ERROR (The vial was expired on 24-Mar-2022 and removed from freezer just prior to administration time on 04-Apr-2022 at 10:26) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 032H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022 at 10:26 AM, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Apr-2022 at 10:26 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was expired on 24-Mar-2022 and removed from freezer just prior to administration time on 04-Apr-2022 at 10:26). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine) and PRODUCT STORAGE ERROR (The vial was expired on 24-Mar-2022 and removed from freezer just prior to administration time on 04-Apr-2022 at 10:26) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   The vial  did not undergo any temperature excursions. All vials were removed from freezer just prior to administration times. No concomitant medications information was reported.   This case was linked to MOD-2022-570968, MOD-2022-571139, MOD-2022-570985 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2022: Follow-up received: Added lot number, administration date and time of vaccine.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose, Fatigue, Vaccination site pain
Clinical narrative: Fatigue; Left arm was really hurting; Patient received a third full dose instead of a booster dose; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), VACCINATION SITE PAIN (Left arm was really hurting) and ACCIDENTAL OVERDOSE (Patient received a third full dose instead of a booster dose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A, 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Oct-2021, the patient experienced FATIGUE (Fatigue), VACCINATION SITE PAIN (Left arm was really hurting) and ACCIDENTAL OVERDOSE (Patient received a third full dose instead of a booster dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE (Fatigue), VACCINATION SITE PAIN (Left arm was really hurting) and ACCIDENTAL OVERDOSE (Patient received a third full dose instead of a booster dose) outcome was unknown.            No concomitant medications were reported. Patient received a third full dose instead of a booster dose and was not immunocompromised   This case was linked to MOD-2022-571007, MOD-2022-570986, MOD-2022-570966, MOD-2022-570982.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired dose given , Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose given , Dose administered after 30-day Use By Date or after manufacturer date of expiry) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 028K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 18-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose given , Dose administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose given , Dose administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. It was reported that administered a dose of Moderna COVID-19 vaccine yesterday18 May 2022, but they realized it expired on 17 May 2022 No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine expired on 02-Apr-2022 and vaccine removed from fridge on 05-APR-2022; Vaccine expired on 02-Apr-2022 and vaccine administered on 05-APR-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 02-Apr-2022 and vaccine administered on 05-APR-2022) and PRODUCT STORAGE ERROR (Vaccine expired on 02-Apr-2022 and vaccine removed from fridge on 05-APR-2022) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 02-Apr-2022 and vaccine administered on 05-APR-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 02-Apr-2022 and vaccine removed from fridge on 05-APR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 02-Apr-2022 and vaccine administered on 05-APR-2022) and PRODUCT STORAGE ERROR (Vaccine expired on 02-Apr-2022 and vaccine removed from fridge on 05-APR-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. BUD date 02-APR-2022 and vaccination was removed from the fridge on 05-APR-22. No treatment information were provided.   This case was linked to MOD-2022-569375.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: sore arm; fatigue; headache; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included Tinnitus (Start Date: 10 years ago Recent change in status such as improvement or worsening: about the same).   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.            Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2022-571116, MOD-2022-571130, MOD-2022-571131 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Accidental overdose, Fatigue, Headache, Pain in extremity
Clinical narrative: sore arm; fatigue; headache; Patient is not immunocompromised and received full  third dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine), PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 028L20A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Tinnitus (Started 10 years ago).   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 19-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine), PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.            It was reported that patient had no improvement or worsening in the status of medical condition, it was same. No concomitant medications were reported. No treatment details were reported. It was reported that the patient was not immunocompromised but received full dose of 1st booster dose of vaccine.   This case was linked to MOD-2022-571116, MOD-2022-571129, MOD-2022-571131 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: sore arm; fatigue; headache; Patient is not immunocompromised and received full  third dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine), PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 028L20A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Tinnitus (Started 10 years ago).   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 19-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine), PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.            It was reported that patient had no improvement or worsening in the status of medical condition, it was same. No concomitant medications were reported. No treatment details were reported. It was reported that the patient was not immunocompromised but received full dose of 1st booster dose of vaccine.   This case was linked to MOD-2022-571116, MOD-2022-571129, MOD-2022-571131 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ear pain
Clinical narrative: sore arm; fatigue; headache; Patient is not immunocompromised and received full  third dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine), PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 028L20A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Tinnitus (Started 10 years ago).   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 19-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, ACCIDENTAL OVERDOSE (Patient is not immunocompromised and received full  third dose of vaccine), PAIN IN EXTREMITY (sore arm), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.            It was reported that patient had no improvement or worsening in the status of medical condition, it was same. No concomitant medications were reported. No treatment details were reported. It was reported that the patient was not immunocompromised but received full dose of 1st booster dose of vaccine.   This case was linked to MOD-2022-571116, MOD-2022-571129, MOD-2022-571131 (Patient Link).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: 2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022); 2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022)) and PRODUCT STORAGE ERROR (2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022)) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 083J21A, 014F21A, 030A21A and 031M20A) for COVID-19 vaccination.     No medical history and allergic conditions were reported.  Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN) from 27-Jul-2020 to an unknown date, DIGOXIN from 18-Dec-2020 to an unknown date, AMLODIPINE from 21-Sep-2021 to an unknown date and ALENDRONATE SODIUM (ALENDRONATE) from 24-Nov-2021 to an unknown date for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 06-May-2022 at 8:30 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022)) and PRODUCT STORAGE ERROR (2 booster doses (0.25mL) of expired Moderna Covid-19 vaccine were administered today (06May2022)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that after getting the vaccine it was discovered later in the day that the vial had expired on 03-May-2022 but had not been pulled for disposal.  No treatment medications were reported  It was unknown if the patient ever been diagnosed with or tested positive for COVID-19.  It was unknown if the patient took any other vaccines within one month prior to any dose of Moderna COVID-19 vaccine.  The vial was initially stored in the refrigerator on 05-May-2022. The vial did not undergo any temperature excursion.
Sex: U
Vaccine: COVID19
Symptoms: Muscle spasms, Taste disorder
Clinical narrative: Bad taste in mouth; Muscle cramps and spasms; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Bad taste in mouth) and MUSCLE SPASMS (Muscle cramps and spasms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2022, the patient experienced TASTE DISORDER (Bad taste in mouth) and MUSCLE SPASMS (Muscle cramps and spasms). The patient was treated with TIZANIDINE in May 2022 for Muscle cramps, at an unspecified dose and frequency and MELOXICAM in May 2022 for Muscle cramps, at an unspecified dose and frequency. At the time of the report, TASTE DISORDER (Bad taste in mouth) and MUSCLE SPASMS (Muscle cramps and spasms) had not resolved.            No concomitant medications were reported. Co-suspect information included the patient had a COVID-19 Treatment. The patient was taking  other medications or products within two weeks of starting COVID-19 treatment.  No treatment medications were specified for bad taste in mouth.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pruritus, Rash, Swelling
Clinical narrative: Rash, swollen, itchy. Rash is at injection site and about 6 inches along my left arm below injection site. This started about 32 hours after the injection.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Aphasia, Aphonia, Body temperature increased, Chills
Clinical narrative: Started feeling sick 5/18; sniffles, coughing, stomach hurting, headache and chills, checked temperature around 4 pm that day and temp was 100.5 started feeling better on 5/21 except then I started losing my voice, 5/22 I had a dry cough but couldn't really talk but could whisper, hurts to swallow to a certain point, 5/23 still dry cough, some very compacted mucus, no voice and hurts to whisper, hurt to swallow
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dysphagia, Headache, Malaise, Productive cough
Clinical narrative: Started feeling sick 5/18; sniffles, coughing, stomach hurting, headache and chills, checked temperature around 4 pm that day and temp was 100.5 started feeling better on 5/21 except then I started losing my voice, 5/22 I had a dry cough but couldn't really talk but could whisper, hurts to swallow to a certain point, 5/23 still dry cough, some very compacted mucus, no voice and hurts to whisper, hurt to swallow
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Started feeling sick 5/18; sniffles, coughing, stomach hurting, headache and chills, checked temperature around 4 pm that day and temp was 100.5 started feeling better on 5/21 except then I started losing my voice, 5/22 I had a dry cough but couldn't really talk but could whisper, hurts to swallow to a certain point, 5/23 still dry cough, some very compacted mucus, no voice and hurts to whisper, hurt to swallow
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Condition aggravated, Dyspnoea, Nasal congestion, Oropharyngeal pain
Clinical narrative: Sore throat, nasal congestion, chest congestion, serious asthma/shortness of breath not managed by an inhaler.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 antibody test negative
Clinical narrative: Sore throat, nasal congestion, chest congestion, serious asthma/shortness of breath not managed by an inhaler.
Age: 34.0
Sex: F
Vaccine: TD
Symptoms: Arthralgia, Back pain, Chest pain, Pain, Pain in extremity
Clinical narrative: Swelling and pain in arm and shoulder, severe pain in lower back,collar bone pain across chest
Age: 34.0
Sex: F
Vaccine: TD
Symptoms: Peripheral swelling
Clinical narrative: Swelling and pain in arm and shoulder, severe pain in lower back,collar bone pain across chest
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture, Cardiac function test, Chest pain, Cholecystectomy, Cholecystitis
Clinical narrative: Prior to this, I had never been informed of any gallbladder-related issues. My slightly elevated cholesterol and BP are genetic, and were managed by diet.  On 2/11/2021 I experienced severe chest pain while driving with my child. I had to pull over because the pain would get worse with every breath. I believe it was 5 full minutes before the pain subsided and I could continue driving.  I experienced this same episodic pain on 2/15, 2/16, and 2/19. I recall the pain coming on in the afternoons but I didn't think to record them at the time. The dates I recall based on events and appointments. On 2/21/2021 the onset of the pain was about 4pm, and this time it did not stop. Eventually, I thought I was having a heart attack.  I had to arrange care for my son as I'm a single mom, and I took myself to the ER at 7pm.  They determined cholecystitis and performed an emergency gallbladder removal on 2/22/2021.  Since then I have had multiple symptoms including extreme fatigue (having to sleep at work, falling asleep while driving), irritability, severe constipation, brain fog.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Constipation, Creatinine renal clearance, Culture urine, Differential white blood cell count, Fatigue
Clinical narrative: Prior to this, I had never been informed of any gallbladder-related issues. My slightly elevated cholesterol and BP are genetic, and were managed by diet.  On 2/11/2021 I experienced severe chest pain while driving with my child. I had to pull over because the pain would get worse with every breath. I believe it was 5 full minutes before the pain subsided and I could continue driving.  I experienced this same episodic pain on 2/15, 2/16, and 2/19. I recall the pain coming on in the afternoons but I didn't think to record them at the time. The dates I recall based on events and appointments. On 2/21/2021 the onset of the pain was about 4pm, and this time it did not stop. Eventually, I thought I was having a heart attack.  I had to arrange care for my son as I'm a single mom, and I took myself to the ER at 7pm.  They determined cholecystitis and performed an emergency gallbladder removal on 2/22/2021.  Since then I have had multiple symptoms including extreme fatigue (having to sleep at work, falling asleep while driving), irritability, severe constipation, brain fog.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Fibrin D dimer, Full blood count, Glomerular filtration rate, Haemoglobin
Clinical narrative: Prior to this, I had never been informed of any gallbladder-related issues. My slightly elevated cholesterol and BP are genetic, and were managed by diet.  On 2/11/2021 I experienced severe chest pain while driving with my child. I had to pull over because the pain would get worse with every breath. I believe it was 5 full minutes before the pain subsided and I could continue driving.  I experienced this same episodic pain on 2/15, 2/16, and 2/19. I recall the pain coming on in the afternoons but I didn't think to record them at the time. The dates I recall based on events and appointments. On 2/21/2021 the onset of the pain was about 4pm, and this time it did not stop. Eventually, I thought I was having a heart attack.  I had to arrange care for my son as I'm a single mom, and I took myself to the ER at 7pm.  They determined cholecystitis and performed an emergency gallbladder removal on 2/22/2021.  Since then I have had multiple symptoms including extreme fatigue (having to sleep at work, falling asleep while driving), irritability, severe constipation, brain fog.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired driving ability, Irritability, Laboratory test, Lipase, Metabolic function test
Clinical narrative: Prior to this, I had never been informed of any gallbladder-related issues. My slightly elevated cholesterol and BP are genetic, and were managed by diet.  On 2/11/2021 I experienced severe chest pain while driving with my child. I had to pull over because the pain would get worse with every breath. I believe it was 5 full minutes before the pain subsided and I could continue driving.  I experienced this same episodic pain on 2/15, 2/16, and 2/19. I recall the pain coming on in the afternoons but I didn't think to record them at the time. The dates I recall based on events and appointments. On 2/21/2021 the onset of the pain was about 4pm, and this time it did not stop. Eventually, I thought I was having a heart attack.  I had to arrange care for my son as I'm a single mom, and I took myself to the ER at 7pm.  They determined cholecystitis and performed an emergency gallbladder removal on 2/22/2021.  Since then I have had multiple symptoms including extreme fatigue (having to sleep at work, falling asleep while driving), irritability, severe constipation, brain fog.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Troponin, Urine analysis
Clinical narrative: Prior to this, I had never been informed of any gallbladder-related issues. My slightly elevated cholesterol and BP are genetic, and were managed by diet.  On 2/11/2021 I experienced severe chest pain while driving with my child. I had to pull over because the pain would get worse with every breath. I believe it was 5 full minutes before the pain subsided and I could continue driving.  I experienced this same episodic pain on 2/15, 2/16, and 2/19. I recall the pain coming on in the afternoons but I didn't think to record them at the time. The dates I recall based on events and appointments. On 2/21/2021 the onset of the pain was about 4pm, and this time it did not stop. Eventually, I thought I was having a heart attack.  I had to arrange care for my son as I'm a single mom, and I took myself to the ER at 7pm.  They determined cholecystitis and performed an emergency gallbladder removal on 2/22/2021.  Since then I have had multiple symptoms including extreme fatigue (having to sleep at work, falling asleep while driving), irritability, severe constipation, brain fog.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dizziness, Dyspnoea, Full blood count
Clinical narrative: Headache, chest pain, leg weakness, dizziness, shortness of breath, chills,
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Metabolic function test, Muscular weakness, SARS-CoV-2 test
Clinical narrative: Headache, chest pain, leg weakness, dizziness, shortness of breath, chills,
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Herpes simplex
Clinical narrative: I have had HSV2 since 2005 with outbreaks occurring every 1-3 years prior to vaccination. After vaccination, outbreaks now occur at least every month, sometimes twice a month. No changes in diet or health, no suppressive medications were used before or after vaccination.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site bruising, Injection site erythema, Injection site pain
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling, Lethargy, Nausea, Vomiting
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint injury, Limb injury, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pallor, Vomiting
Clinical narrative: Systemic: Nausea-Medium, Systemic: Vomiting-Severe, Additional Details: patient looked pale, was advised to be seated and wait it out - and he was given gatorade to help replenish electrolytes and keep hydrated.  He did wear a very thick jacket and the store is stuffy, with low ventilation
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: HOSPITALIZATION
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Severe
Age: 1.0
Sex: M
Vaccine: HIBV
Symptoms: Expired product administered
Clinical narrative: HIB vaccine expired on  5/6/2022 and administered on 5/16/2022 ; will need to be repeated.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Death
Clinical narrative: 12/9/2021 - Sent to ER from Oncology for SOB/hypoxia and immunocompromised due to 3/5 chemo completed for stage IV lung Ca. POC Covid test positive. On arrival temp 37, RR 18, SpO2 94 on supp O2, BP 131/87, WBC 7.7. Chest xray revealed bilateral infiltrates concerning for Covid 19. Admitted to Telemetry for covid pneumonia.  Started on Vancomycin, Cefepime, Decadron, Lovenox, and Remdesivir. 12/10 -  Baricitinib added to treatment. On high flow NC for O2, FiO2 65% with 40L flow. BP 152/95, HR 123.   12/11 - having asymptomatic runs of V tach and dissiculty swallowing. Kept NPO. O2 requirements not improving but not worsening. Changed steriod to Solu-medrol on 12/12. mech diet initiated 12/14- 5 day course Remdesivir complete. Baricitinib d/c 12/13 - WBC trending down. increasing hypoxia/HR - Hypoxia/tachycardia increasing -placed on BiPAP 100% FiO 12/15 - Decision for Palliative /comfort care vs aggressive treatment.  12/18 - Patient expired @1220.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysphagia, Dyspnoea, Hypoxia, Lung infiltration, Nothing by mouth order
Clinical narrative: 12/9/2021 - Sent to ER from Oncology for SOB/hypoxia and immunocompromised due to 3/5 chemo completed for stage IV lung Ca. POC Covid test positive. On arrival temp 37, RR 18, SpO2 94 on supp O2, BP 131/87, WBC 7.7. Chest xray revealed bilateral infiltrates concerning for Covid 19. Admitted to Telemetry for covid pneumonia.  Started on Vancomycin, Cefepime, Decadron, Lovenox, and Remdesivir. 12/10 -  Baricitinib added to treatment. On high flow NC for O2, FiO2 65% with 40L flow. BP 152/95, HR 123.   12/11 - having asymptomatic runs of V tach and dissiculty swallowing. Kept NPO. O2 requirements not improving but not worsening. Changed steriod to Solu-medrol on 12/12. mech diet initiated 12/14- 5 day course Remdesivir complete. Baricitinib d/c 12/13 - WBC trending down. increasing hypoxia/HR - Hypoxia/tachycardia increasing -placed on BiPAP 100% FiO 12/15 - Decision for Palliative /comfort care vs aggressive treatment.  12/18 - Patient expired @1220.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Positive airway pressure therapy, SARS-CoV-2 test positive, Ventricular tachycardia, White blood cell count normal
Clinical narrative: 12/9/2021 - Sent to ER from Oncology for SOB/hypoxia and immunocompromised due to 3/5 chemo completed for stage IV lung Ca. POC Covid test positive. On arrival temp 37, RR 18, SpO2 94 on supp O2, BP 131/87, WBC 7.7. Chest xray revealed bilateral infiltrates concerning for Covid 19. Admitted to Telemetry for covid pneumonia.  Started on Vancomycin, Cefepime, Decadron, Lovenox, and Remdesivir. 12/10 -  Baricitinib added to treatment. On high flow NC for O2, FiO2 65% with 40L flow. BP 152/95, HR 123.   12/11 - having asymptomatic runs of V tach and dissiculty swallowing. Kept NPO. O2 requirements not improving but not worsening. Changed steriod to Solu-medrol on 12/12. mech diet initiated 12/14- 5 day course Remdesivir complete. Baricitinib d/c 12/13 - WBC trending down. increasing hypoxia/HR - Hypoxia/tachycardia increasing -placed on BiPAP 100% FiO 12/15 - Decision for Palliative /comfort care vs aggressive treatment.  12/18 - Patient expired @1220.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: 12/17/2021 - Patient alerted to Covid + status on discharge 12/15  for (VRE UTI). Patient came back to ED 12/17 with weakness/SOB. Temp 99.1 initial then 103.2, HR 107, RR 18, sat 95% on 2L NC. BP WNL.  Received Vancomycin, Meropenem, Daptomycin, and decadron. Chest XR reveals bil pulm infiltrates. Admit for Sepsis/Covid pneumonia/Recurrent UTI failed to continue treatment - too weak.  12/18 - Remdesivir/Lovenox started, Dapto/Meropenem,Decadron continued. Saturating 96% 2L (norm). Fever/Tachycardia - sepsis resolved 12/21 - SOB resolved. WBC increased from initial 8.7 to 10.9. Remdesivir course complete. Meropenum d/c. Daptomycin continued 12/22 - WBC improved 9.9.  12/23 - Dapto stopped. transitioned to oral Linezolid.  12/24 - Discharged to home.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Lung infiltration, Pyrexia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: 12/17/2021 - Patient alerted to Covid + status on discharge 12/15  for (VRE UTI). Patient came back to ED 12/17 with weakness/SOB. Temp 99.1 initial then 103.2, HR 107, RR 18, sat 95% on 2L NC. BP WNL.  Received Vancomycin, Meropenem, Daptomycin, and decadron. Chest XR reveals bil pulm infiltrates. Admit for Sepsis/Covid pneumonia/Recurrent UTI failed to continue treatment - too weak.  12/18 - Remdesivir/Lovenox started, Dapto/Meropenem,Decadron continued. Saturating 96% 2L (norm). Fever/Tachycardia - sepsis resolved 12/21 - SOB resolved. WBC increased from initial 8.7 to 10.9. Remdesivir course complete. Meropenum d/c. Daptomycin continued 12/22 - WBC improved 9.9.  12/23 - Dapto stopped. transitioned to oral Linezolid.  12/24 - Discharged to home.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia, Urinary tract infection, White blood cell count increased
Clinical narrative: 12/17/2021 - Patient alerted to Covid + status on discharge 12/15  for (VRE UTI). Patient came back to ED 12/17 with weakness/SOB. Temp 99.1 initial then 103.2, HR 107, RR 18, sat 95% on 2L NC. BP WNL.  Received Vancomycin, Meropenem, Daptomycin, and decadron. Chest XR reveals bil pulm infiltrates. Admit for Sepsis/Covid pneumonia/Recurrent UTI failed to continue treatment - too weak.  12/18 - Remdesivir/Lovenox started, Dapto/Meropenem,Decadron continued. Saturating 96% 2L (norm). Fever/Tachycardia - sepsis resolved 12/21 - SOB resolved. WBC increased from initial 8.7 to 10.9. Remdesivir course complete. Meropenum d/c. Daptomycin continued 12/22 - WBC improved 9.9.  12/23 - Dapto stopped. transitioned to oral Linezolid.  12/24 - Discharged to home.
Age: 34.0
Sex: F
Vaccine: MENB
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Brain stem auditory evoked response, Computerised tomogram, Condition aggravated, Hypoacusis, Laboratory test
Clinical narrative: Over the course of an hour after the first shot, the ringing in my ears tripled in volume and has stayed that way since. I never had any signs of tinnitus or hearing damage until 2 weeks after my first shot.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Over the course of an hour after the first shot, the ringing in my ears tripled in volume and has stayed that way since. I never had any signs of tinnitus or hearing damage until 2 weeks after my first shot.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Atelectasis, Blood pressure systolic decreased, Body temperature increased
Clinical narrative: 1/26/2022- Presents to ER from group home for SOB. T-101.2 , HR-105, SPo2 80's placed on 2L o2 via NC increased to 90's. Hypotensive with systolic BP in mid 70's requiring 2L NS bolus. CRP-2.0. Ct scan-patchy airspace disease at the medial aspect of the left lower lobe consistent with atelectasis and pneumonia. Admit acute respiratory failure due to bilateral Covid-19.Start IV ceftrixone, IV doxycycline, IV remdesivir, decadron and baricitinib. Continue aspirin and Eliquis.  1/27/2022- BP dropped to 70/50's requiring pressor support, norepinpehrine and IV vancomycin. Started on BiPAP d/t hypercapnia Pco2 51.3. 1/29/2022- BP 127/80. Started on Cefepime for UTI. Satting at 95-99% on 3-4L via NC.  1/30/2022-Not tolerating Bipap, is satting on RA around high 90's. Transitioned to RA and Supplemental o2 as needed. BP improved 134/70, pressors d/c put on midodrine.  2/4/2022- Continues on supplemental O2 as needed. Afebrile.  2/7/2022- CRP-1.6. Afebrile. BP-104/70. Spo2 low 90's on RA. Discharged to group home.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein normal, COVID-19, Computerised tomogram thorax abnormal, Device intolerance, Dyspnoea
Clinical narrative: 1/26/2022- Presents to ER from group home for SOB. T-101.2 , HR-105, SPo2 80's placed on 2L o2 via NC increased to 90's. Hypotensive with systolic BP in mid 70's requiring 2L NS bolus. CRP-2.0. Ct scan-patchy airspace disease at the medial aspect of the left lower lobe consistent with atelectasis and pneumonia. Admit acute respiratory failure due to bilateral Covid-19.Start IV ceftrixone, IV doxycycline, IV remdesivir, decadron and baricitinib. Continue aspirin and Eliquis.  1/27/2022- BP dropped to 70/50's requiring pressor support, norepinpehrine and IV vancomycin. Started on BiPAP d/t hypercapnia Pco2 51.3. 1/29/2022- BP 127/80. Started on Cefepime for UTI. Satting at 95-99% on 3-4L via NC.  1/30/2022-Not tolerating Bipap, is satting on RA around high 90's. Transitioned to RA and Supplemental o2 as needed. BP improved 134/70, pressors d/c put on midodrine.  2/4/2022- Continues on supplemental O2 as needed. Afebrile.  2/7/2022- CRP-1.6. Afebrile. BP-104/70. Spo2 low 90's on RA. Discharged to group home.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypercapnia, Hypotension, Lung disorder, PCO2 increased, Pneumonia
Clinical narrative: 1/26/2022- Presents to ER from group home for SOB. T-101.2 , HR-105, SPo2 80's placed on 2L o2 via NC increased to 90's. Hypotensive with systolic BP in mid 70's requiring 2L NS bolus. CRP-2.0. Ct scan-patchy airspace disease at the medial aspect of the left lower lobe consistent with atelectasis and pneumonia. Admit acute respiratory failure due to bilateral Covid-19.Start IV ceftrixone, IV doxycycline, IV remdesivir, decadron and baricitinib. Continue aspirin and Eliquis.  1/27/2022- BP dropped to 70/50's requiring pressor support, norepinpehrine and IV vancomycin. Started on BiPAP d/t hypercapnia Pco2 51.3. 1/29/2022- BP 127/80. Started on Cefepime for UTI. Satting at 95-99% on 3-4L via NC.  1/30/2022-Not tolerating Bipap, is satting on RA around high 90's. Transitioned to RA and Supplemental o2 as needed. BP improved 134/70, pressors d/c put on midodrine.  2/4/2022- Continues on supplemental O2 as needed. Afebrile.  2/7/2022- CRP-1.6. Afebrile. BP-104/70. Spo2 low 90's on RA. Discharged to group home.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Positive airway pressure therapy, Urinary tract infection
Clinical narrative: 1/26/2022- Presents to ER from group home for SOB. T-101.2 , HR-105, SPo2 80's placed on 2L o2 via NC increased to 90's. Hypotensive with systolic BP in mid 70's requiring 2L NS bolus. CRP-2.0. Ct scan-patchy airspace disease at the medial aspect of the left lower lobe consistent with atelectasis and pneumonia. Admit acute respiratory failure due to bilateral Covid-19.Start IV ceftrixone, IV doxycycline, IV remdesivir, decadron and baricitinib. Continue aspirin and Eliquis.  1/27/2022- BP dropped to 70/50's requiring pressor support, norepinpehrine and IV vancomycin. Started on BiPAP d/t hypercapnia Pco2 51.3. 1/29/2022- BP 127/80. Started on Cefepime for UTI. Satting at 95-99% on 3-4L via NC.  1/30/2022-Not tolerating Bipap, is satting on RA around high 90's. Transitioned to RA and Supplemental o2 as needed. BP improved 134/70, pressors d/c put on midodrine.  2/4/2022- Continues on supplemental O2 as needed. Afebrile.  2/7/2022- CRP-1.6. Afebrile. BP-104/70. Spo2 low 90's on RA. Discharged to group home.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Atrial fibrillation, Blood gases, COVID-19
Clinical narrative: 1/28/2022- Presented to ER, due worsening SOB and productive cough x 2 weeks. Covid + test on 1/20/2022. Admit acute hypoxic respiratory failure secondary to COPD exacerbation with underlying Covid positive status with Acute. Afebrile, P-124 and BP-175/81. EKG- A-Fib with RVR. ABG-7.4/33.1/78/21.2/-2.5  on 2L via NC.WBC-14. Chest CT-No evidence of acute pulmonary disease. Left lower lobe acute nonocclusive embolus. Started on IV diltiazem, Solu-medrol, Remdesivir, ceftriaxone, Lovenox and doxycycline.  1/30/3033- Dilitaxzem changed to PO. Exertional SOB continues. BP-116/66 ans Spo2 96% on 2L.  2/1/2022- D/C remdesivir and IV ceftriaxone. Currently tolerating RA.  2/3/2022- Continue doxycycline, eliquis and dilitazem. WBC-10.9. Afebrile, BP-181/76 and P-78. Spo2 98% on RA. Discharge to home
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal, Condition aggravated, Dyspnoea, Dyspnoea exertional
Clinical narrative: 1/28/2022- Presented to ER, due worsening SOB and productive cough x 2 weeks. Covid + test on 1/20/2022. Admit acute hypoxic respiratory failure secondary to COPD exacerbation with underlying Covid positive status with Acute. Afebrile, P-124 and BP-175/81. EKG- A-Fib with RVR. ABG-7.4/33.1/78/21.2/-2.5  on 2L via NC.WBC-14. Chest CT-No evidence of acute pulmonary disease. Left lower lobe acute nonocclusive embolus. Started on IV diltiazem, Solu-medrol, Remdesivir, ceftriaxone, Lovenox and doxycycline.  1/30/3033- Dilitaxzem changed to PO. Exertional SOB continues. BP-116/66 ans Spo2 96% on 2L.  2/1/2022- D/C remdesivir and IV ceftriaxone. Currently tolerating RA.  2/3/2022- Continue doxycycline, eliquis and dilitazem. WBC-10.9. Afebrile, BP-181/76 and P-78. Spo2 98% on RA. Discharge to home
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Productive cough, Pulmonary embolism, SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: 1/28/2022- Presented to ER, due worsening SOB and productive cough x 2 weeks. Covid + test on 1/20/2022. Admit acute hypoxic respiratory failure secondary to COPD exacerbation with underlying Covid positive status with Acute. Afebrile, P-124 and BP-175/81. EKG- A-Fib with RVR. ABG-7.4/33.1/78/21.2/-2.5  on 2L via NC.WBC-14. Chest CT-No evidence of acute pulmonary disease. Left lower lobe acute nonocclusive embolus. Started on IV diltiazem, Solu-medrol, Remdesivir, ceftriaxone, Lovenox and doxycycline.  1/30/3033- Dilitaxzem changed to PO. Exertional SOB continues. BP-116/66 ans Spo2 96% on 2L.  2/1/2022- D/C remdesivir and IV ceftriaxone. Currently tolerating RA.  2/3/2022- Continue doxycycline, eliquis and dilitazem. WBC-10.9. Afebrile, BP-181/76 and P-78. Spo2 98% on RA. Discharge to home
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: NO SYMPTOMS
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: no symptoms
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: no symptoms
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine had temperature excursion of 0.5 degrees F warm for 1 hour
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza virus test negative, Laboratory test normal, Oropharyngeal pain, Pain in extremity, Paranasal sinus hypersecretion
Clinical narrative: I had a sore throat and some drainage and achiness in my legs. This started in March, which was months after taking the vaccine. I tested for Covid and other influenza problems but all tests did come back negative. Currently it is towards the end of May and I am still experiencing these problems, even though they are lesser now. Not sure if this is a late side effect that is coming from vaccine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: I had a sore throat and some drainage and achiness in my legs. This started in March, which was months after taking the vaccine. I tested for Covid and other influenza problems but all tests did come back negative. Currently it is towards the end of May and I am still experiencing these problems, even though they are lesser now. Not sure if this is a late side effect that is coming from vaccine.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: SOB, chest pain
Age: 22.0
Sex: F
Vaccine: HEP
Symptoms: Injection site erythema
Clinical narrative: Redness at and around the injection site greater than 2 inches in diameter. No other symptoms. No treatment provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: NO SYMPTOMS
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine may have had temperature excursion
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Audiogram, Deafness, Injection
Clinical narrative: I started experiencing hearing loss after my second booster vaccine. I made an appointment with the ENT specialist, he gave me a steroid injection in my inner ear. I have not recovered and I am being monitored for any changes.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Ear, nose and throat examination, Fatigue, Headache, Tinnitus
Clinical narrative: Constant unilateral  left ear tinnitus, sounds like Morse Code, sometimes like ?flatline?, headaches, fatigue.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac ablation, Cardioversion, Echocardiogram, Electrocardiogram
Clinical narrative: Atrial fibrillation requiring cardioversion and eventual ablation
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test
Clinical narrative: Atrial fibrillation requiring cardioversion and eventual ablation
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: no symptoms
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine may have had temperature excursion
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular, Ultrasound scan
Clinical narrative: I had irregular periods and it stop for three months and when it did come back I had to go see my doctor because of my flow was very, very severe and I never bleed like that before. So I had to go see my OB GYN Dr. and she prescribe  Tranexamic Acid to stop the heavy flowing. Am still having had very heavy flow. I didn't have any of this before getting the vaccine. I had heavy periods but nothing like this. I started with dose 2 & 3 of the vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: no symptoms